Actinic Keratosis Treatment Market Size, Share & Trends Report

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-940-1
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Therapy
                       1.1.2. Drug class
                       1.1.3. End-use
                       1.1.4. Regional scope
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Therapy outlook
                       2.2.2. Drug class outlook
                       2.2.3. End-use outlook
                       2.2.4. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Actinic Keratosis Treatment Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. Actinic Keratosis Treatment Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. Actinic Keratosis Treatment Market: Therapy Estimates & Trend Analysis
                   4.1. Actinic Keratosis Treatment Market: Key Takeaways
                   4.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Topical
                       4.3.1. Topical market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Surgery
                       4.4.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.5. Photodynamic Therapy
                       4.5.1. Photodynamic therapy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Actinic Keratosis Treatment Market: Drug Class Estimates & Trend Analysis
                   5.1. Actinic Keratosis Treatment Market: Key Takeaways
                   5.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Nucleoside Metabolic Inhibitor
                       5.3.1. Nucleoside metabolic inhibitor market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. NSAIDS
                       5.4.1. NSAIDS market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Immune Response Modifiers
                       5.5.1. Immune response modifiers market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.6. Photoenhancers
                       5.6.1. Photoenhancers market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.7. Others
                       5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Actinic Keratosis Treatment Market: End-use Estimates & Trend Analysis
                   6.1. Actinic Keratosis Treatment Market: Key Takeaways
                   6.2. Actinic Keratosis Treatment Market: Movement & Market Share Analysis, 2022 & 2030
                   6.3. Hospitals
                       6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.4. Private Clinics Delivery
                       6.4.1. Private clinics delivery market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.5. Homecare
                       6.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
                   6.6. Others
                       6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Actinic Keratosis Treatment Market: Regional Estimates & Trend Analysis
                   7.1. Regional Outlook
                   7.2. Actinic Keratosis Treatment Market by Region: Key Takeaway
                   7.3. North America
                       7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.3.2. U.S.
                           7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.3.3. Canada
                           7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   7.4. Europe
                       7.4.1. UK
                           7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.2. Germany
                           7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.3. France
                           7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.4. Italy
                           7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.5. Spain
                           7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.6. Sweden
                           7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.7. Norway
                           7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.4.8. Denmark
                           7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   7.5. Asia Pacific
                       7.5.1. Japan
                           7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.5.2. China
                           7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.5.3. India
                           7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.5.4. Australia
                           7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.5.5. Thailand
                           7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.5.6. South Korea
                           7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   7.6. Latin America
                       7.6.1. Brazil
                           7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.6.2. Mexico
                           7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.6.3. Argentina
                           7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   7.7. MEA
                       7.7.1. Saudi Arabia
                           7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.7.2. South Africa
                           7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.7.3. UAE
                           7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       7.7.4. Kuwait
                           7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Market Participant Categorization
                       8.2.1. Almirall S.A.
                           8.2.1.1. Company overview
                           8.2.1.2. Financial performance
                           8.2.1.3. Product benchmarking
                           8.2.1.4. Strategic initiatives
                       8.2.2. LEO Pharma A/S
                           8.2.2.1. Company overview
                           8.2.2.2. Financial performance
                           8.2.2.3. Product benchmarking
                           8.2.2.4. Strategic initiatives
                       8.2.3. Sun Pharmaceutical Industries Ltd.
                           8.2.3.1. Company overview
                           8.2.3.2. Financial performance
                           8.2.3.3. Product benchmarking
                           8.2.3.4. Strategic initiatives
                       8.2.4. Novartis AG
                           8.2.4.1. Company overview
                           8.2.4.2. Financial performance
                           8.2.4.3. Product benchmarking
                           8.2.4.4. Strategic initiatives
                       8.2.5. GALDERMA
                           8.2.5.1. Company overview
                           8.2.5.2. Financial performance
                           8.2.5.3. Product benchmarking
                           8.2.5.4. Strategic initiatives
                       8.2.6. Ortho Dermatologics (Bausch Health Companies Inc.)
                           8.2.6.1. Company overview
                           8.2.6.2. Financial performance
                           8.2.6.3. Product benchmarking
                           8.2.6.4. Strategic initiatives
                       8.2.7. BIOFRONTERA AG
                           8.2.7.1. Company overview
                           8.2.7.2. Financial performance
                           8.2.7.3. Product benchmarking
                           8.2.7.4. Strategic initiatives
                       8.2.8. Hill Dermaceuticals, Inc.
                           8.2.8.1. Company overview
                           8.2.8.2. Financial performance
                           8.2.8.3. Product benchmarking
                           8.2.8.4. Strategic initiatives 


List of Tables

1. List of Abbreviations
2. North America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
3. North America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
4. North America actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
5. North America actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
6. U.S. actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
7. U.S. actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
8. U.S. actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
9. Canada actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
10. Canada actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
11. Canada actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
12. Europe actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
13. Europe actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
14. Europe actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
15. Europe actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
16. Germany actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
17. Germany actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
18. Germany actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
19. UK actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
20. UK actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
21. UK actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
22. France actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
23. France actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
24. France actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
25. Italy actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
26. Italy actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
27. Italy actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
28. Spain actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
29. Spain actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
30. Spain actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
31. Sweden actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
32. Sweden actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
33. Sweden actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
34. Norway actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
35. Norway actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
36. Norway actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
37. Denmark actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
38. Denmark actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
39. Denmark actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
40. Asia Pacific actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
41. Asia Pacific actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
42. Asia Pacific actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
43. Asia Pacific actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
44. China actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
45. China actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
46. China actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
47. Japan actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
48. Japan actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
49. Japan actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
50. India actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
51. India actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
52. India actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
53. Thailand actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
54. Thailand actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
55. Thailand actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
56. South Korea actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
57. South Korea actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
58. South Korea actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
59. Latin America actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
60. Latin America actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
61. Latin America actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
62. Latin America actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
63. Brazil actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
64. Brazil actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
65. Brazil actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
66. Mexico actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
67. Mexico actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
68. Mexico actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
69. Argentina actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
70. Argentina actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
71. Argentina actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
72. Middle East and Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
73. Middle East and Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
74. Middle East and Africa actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
75. Middle East and Africa actinic keratosis treatment market, by region, 2018 - 2030 (USD Million)
76. South Africa actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
77. South Africa actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
78. South Africa actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
79. Saudi Arabia actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
80. Saudi Arabia actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
81. Saudi Arabia actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
82. UAE actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
83. UAE actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
84. UAE actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)
85. Kuwait actinic keratosis treatment market, by therapy, 2018 - 2030 (USD Million)
86. Kuwait actinic keratosis treatment market, by drug class, 2018 - 2030 (USD Million)
87. Kuwait actinic keratosis treatment market, by end-use, 2018 - 2030 (USD Million)


List of Figures

1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. Value-chain-based sizing & forecasting
6. QFD modeling for market share assessment
7. Market formulation & validation
8. Actinic keratosis treatment: Market outlook
9. Actinic keratosis treatment: Competitive insights
10. Parent market outlook
11. Related/ancillary market outlook
12. Penetration and growth prospect mapping
13. Industry value chain analysis
14. Actinic keratosis treatment market driver impact
15. Actinic keratosis treatment market restraint impact
16. Actinic keratosis treatment market strategic initiatives analysis
17. Actinic keratosis treatment market: Therapy movement analysis
18. Actinic keratosis treatment market: Therapy outlook and key takeaways
19. Topical market estimates and forecasts, 2018 - 2030 (USD Million)
20. Surgery market estimates and forecasts, 2018 - 2030 (USD Million)
21. Photodynamic therapy market estimates and forecasts, 2018 - 2030 (USD Million)
22. Actinic keratosis treatment market: Drug class movement analysis
23. Actinic keratosis treatment market: Drug class outlook and key takeaways
24. Nucleoside metabolic inhibitor market estimates and forecasts, 2018 - 2030 (USD Million)
25. NSAIDS market estimates and forecasts, 2018 - 2030 (USD Million)
26. Immune response modifiers market estimates and forecasts, 2018 - 2030 (USD Million)
27. Photoenhancers market estimates and forecasts, 2018 - 2030 (USD Million)
28. Others market estimates and forecasts, 2018 - 2030 (USD Million)
29. Actinic keratosis treatment market: End-use movement analysis
30. Actinic keratosis treatment market: End-use outlook and key takeaways
31. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
32. Private clinics delivery market estimates and forecasts, 2018 - 2030 (USD Million)
33. Homecare market estimates and forecasts, 2018 - 2030 (USD Million)
34. Others market estimates and forecasts, 2018 - 2030 (USD Million)
35. Global actinic keratosis treatment market: Regional movement analysis
36. Global actinic keratosis treatment market: Regional outlook and key takeaways
37. North America market estimates and forecasts, 2018 - 2030 (USD Million)
38. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
39. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
40. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
41. UK market estimates and forecasts, 2018 - 2030 (USD Million)
42. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
43. France market estimates and forecasts, 2018 - 2030 (USD Million)
44. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
45. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
46. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
47. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
48. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
49. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
50. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
51. China market estimates and forecasts, 2018 - 2030 (USD Million)
52. India market estimates and forecasts, 2018 - 2030 (USD Million)
53. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
54. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
55. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
56. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
57. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
58. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
59. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
60. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
61. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
62. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
63. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
64. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon